NY A 44
in committeeRequires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities
New York · 2025-2026 Regular Session · lower
Description
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
- Introduced
- —
- Status date
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Amy Paulinprimary
- Dana Levenbergcosponsor
- Michael Novakhovcosponsor
- Al Taylorcosponsor
- Steven Otiscosponsor
Committees
Not provided by source.
Action timeline
2025-01-08
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- A44Compare
Documents
- application/pdf(no extracted text yet)
- text/html
Votes
Not provided by source.
Related bills
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 44. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.